Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
whereas inhibition of tumor growth is maintained for the entire 28-day treatment period in Ro 5126766-treated mice
17)7-4-5-8(9(6-7)18(22)23)13(21)12-10(19)2-1-3-11(12)20/h4-6
Kallifatidis G
is an experimental drug candidate for the treatment of fragile X syndrome
TCO-PEG8-NHS ester Catalog No.:M13097-2 whereas inhibition of tumor growthTCO PEG8 NHS ester is a PEG based PROTAC linker can be used in the synthesis of PROTACs. Product information CAS Number: 2353409 95 5 Molecular Weight: 690. 78 Formula: C32H54N2O14 Chemical Name: 2,5 dioxopyrrolidin 1 yl 1 ({[(4Z) cyclooct 4 en 1 yloxy]carbonyl}amino) 3,6,9,12,15,18,21,24 octaoxaheptacosan 27 oate Smiles: O=C(CCOCCOCCOCCOCCOCCOCCOCCOCCNC(=O)OC1CCCC=CCC1)ON1C(=O)CCC1=O c: 36 InChiKey: QTIJRGCLYYSKEU UPHRSURJSA N InChi: InChI=1S